Coronavirus evacuees monitored at Texas Center for Infectious Disease

Facility’s primary function is to treat tuberculosis patients


The Texas Center for Infectious Disease (TCID) in San Antonio is housing at least five people who tested positive for the coronavirus after being brought to Joint Base San Antonio-Lackland, according to an article on the KSAT website.

More than 18 people have been transferred off base, either to TCID or local hospitals, after showing symptoms of the virus or while awaiting test results.

Local leaders urge Department of Defense to keep coronavirus evacuees away from local healthcare facilities

It's unclear exactly how many of those 18 people are now at TCID.

The primary purpose of TCID is to treat tuberculosis patients.

Read the article.



March 12, 2020


Topic Area: Infection Control


Recent Posts

Beyond Backup Generators: Building Layered Energy Resilience

Backup generators still matter, but they are just one piece of a larger puzzle.


Shannon Health System to Acquire Scenic Mountain Medical Center

The signing of the asset purchase agreement begins the asset purchase closing process, which is expected to be completed in the coming months.


First Rehabilitation Resources Ensnared in Email Breach

First Rehabilitation Resources has no evidence that any information has been misused by the malicious actor. 


Hand, Foot and Mouth Disease on the Rise

A number of states are reporting an uptick in HFMD, a highly contagious viral illness that primarily affects infants and young children.


BayCare Reveals Pagidipati Children's Hospital at St. Joseph's

It is a freestanding facility scheduled to open in 2030.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
 
 

Healthcare Facilities Today membership includes free email newsletters from our facility-industry brands.

Facebook   Twitter   LinkedIn   Posts

Copyright © 2023 TradePress. All rights reserved.